Analysis reveals enhanced CAR T cell activity in melanoma models, suggesting RNA-sensing systems may reduce treatment resistance.
CAR T cell frequency, activation marker expression, death receptor expression on tumor cells, representative FACS blots of CAR T cell analysis in the TME of melanoma-bearing mice, and the experimental setups of murine PDAC CAR T cell models
No takes yet. Share an insight, caveat, or question.
Soliman et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: